Skip to Content
Resources

AHIP Comments on Special Registrations for Telemedicine and Limited State Telemedicine Registrations

Comment Letter

AHIP comments on proposed rules addressing the prescribing of controlled substance medications through telemedicine and virtual interactions.

Document Info

Published on Mar 18, 2025

Download and read the full Resource.

Resource Details

AHIP Comments on the proposed rule on Special Registrations for Telemedicine and Limited State Telemedicine Registrations, published in the Federal Register on January 17, 2025.

Overview

AHIP supports increasing access to medications prescribed via virtual interactions, with appropriate guardrails. Affordable, accessible medications help promote and maintain health and well-being. Experience has demonstrated that telemedicine is an important part of the health care delivery continuum. Telemedicine’s value as a modality is supported by recent data showing it is a cost-effective, convenient means of delivering high quality care. Telemedicine can expand access to care, especially for rural populations where there is limited access to in-person care, and reduces barriers such as transportation, childcare, and time needed off from work.